Cibus Stock

cibus.comHealthcareFounded: 2001Funding to Date: $183.76MM

Developer of a plant and microbial breeding platform intended to advance in non-transgenic breeding technologies. The company's platform uses proprietary and highly differentiated non-transgenic gene-editing technologies to offer site-specific edits of native genes with no introduction of foreign DNA, enabling biologists to avail non-transgenic traits for most major crops.

Register for Details

For more details on financing and valuation for Cibus, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Cibus.

Register Today

Team

Management Team

Peter Beetham Ph.D
Founder, President, Board Member & Chief Executive Officer
James Hinrichs
Chief Financial Officer
Greg Gocal Ph.D
Co-Founder, Chief Scientific Officer & Executive Vice President
Jonathan Wygant
Chief Accounting Officer
David Songstad Ph.D
Director of Research and Cell Biology
Kay Kuenker
Executive Vice President, Strategy
Rory Riggs
Co-Founder & Chairman
Keith Walker Ph.D
Co-Founder & Board Member

Board Members

Eugene Linden
Alain Pompidou
Gerhard Prante Ph.D
Keith Walker Ph.D
Mark Finn
Richard Spizzirri Ph.D
Peter Beetham Ph.D
Rory Riggs
Christopher Richards Ph.D
Jean-Pierre Lehmann
Mark Lu

Other companies like Cibus in the Healthcare sector

Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$4.8B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM

News

San Diego-based Cibus Ltd, a provider of advanced plant-breeding technologies, has filed for an IPO. The number of shares that will be sold as well as the stock's pricing terms have yet to be set. Cibus is planning on listing the stock on the NASDAQ under the ticker symbol "CBUS." Morgan Stanley and BofA Merill Lynch are the lead underwriters. The company's backers include Fidelity Management and Research Company, Alexandria Venture Investments and Cormorant Asset Management.
San Diego-based Cibus Ltd, a provider of advanced plant-breeding technologies has priced its IPO of over 6.6 million shares at between $14 and $16 per share. The company plans on trading the stock on the NASDAQ under the ticker symbol "CBUS." Morgan Stanley and BofA Merrill Lynch are the lead underwriters. The company’s backers include Fidelity Management and Research Company, Alexandria Venture Investments and Cormorant Asset Management.